These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19584445)

  • 1. The effects of enhanced zinc on spatial memory and plaque formation in transgenic mice.
    Linkous DH; Adlard PA; Wanschura PB; Conko KM; Flinn JM
    J Alzheimers Dis; 2009; 18(3):565-79. PubMed ID: 19584445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8).
    Doggui S; Brouillette J; Chabot JG; Farso M; Quirion R
    Neurodegener Dis; 2010; 7(1-3):88-95. PubMed ID: 20173334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid beta and impairment in multiple memory systems in older transgenic APP TgCRND8 mice.
    Hanna A; Horne P; Yager D; Eckman C; Eckman E; Janus C
    Genes Brain Behav; 2009 Oct; 8(7):676-84. PubMed ID: 19531156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
    Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L
    J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease.
    Grossi C; Francese S; Casini A; Rosi MC; Luccarini I; Fiorentini A; Gabbiani C; Messori L; Moneti G; Casamenti F
    J Alzheimers Dis; 2009; 17(2):423-40. PubMed ID: 19363260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent increase in lysosome-associated membrane protein 1 and early-onset behavioral deficits in APPSL transgenic mouse model of Alzheimer's disease.
    Hashimoto T; Ogino K; Shin RW; Kitamoto T; Kikuchi T; Shimizu N
    Neurosci Lett; 2010 Jan; 469(2):273-7. PubMed ID: 20025930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
    Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
    Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
    Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased acetylcholine release is correlated to memory impairment in the Tg2576 transgenic mouse model of Alzheimer's disease.
    Watanabe T; Yamagata N; Takasaki K; Sano K; Hayakawa K; Katsurabayashi S; Egashira N; Mishima K; Iwasaki K; Fujiwara M
    Brain Res; 2009 Jan; 1249():222-8. PubMed ID: 18996097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of metals on spatial memory in a transgenic mouse model of Alzheimer's disease.
    Railey AM; Groeber CM; Flinn JM
    J Alzheimers Dis; 2011; 24(2):375-81. PubMed ID: 21239856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer's transgenic mouse lines differing in Abeta deposition.
    Leighty RE; Nilsson LN; Potter H; Costa DA; Low MA; Bales KR; Paul SM; Arendash GW
    Behav Brain Res; 2004 Aug; 153(1):107-21. PubMed ID: 15219712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic mouse model of Alzheimer's disease.
    Ribes D; Colomina MT; Vicens P; Domingo JL
    Exp Neurol; 2008 Dec; 214(2):293-300. PubMed ID: 18834880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease.
    Ambrée O; Richter H; Sachser N; Lewejohann L; Dere E; de Souza Silva MA; Herring A; Keyvani K; Paulus W; Schäbitz WR
    Neurobiol Aging; 2009 Aug; 30(8):1192-204. PubMed ID: 18079024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related accumulation of Reelin in amyloid-like deposits.
    Knuesel I; Nyffeler M; Mormède C; Muhia M; Meyer U; Pietropaolo S; Yee BK; Pryce CR; LaFerla FM; Marighetto A; Feldon J
    Neurobiol Aging; 2009 May; 30(5):697-716. PubMed ID: 17904250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease.
    Chen G; Chen KS; Knox J; Inglis J; Bernard A; Martin SJ; Justice A; McConlogue L; Games D; Freedman SB; Morris RG
    Nature; 2000 Dec 21-28; 408(6815):975-9. PubMed ID: 11140684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice.
    Cao D; Fukuchi K; Wan H; Kim H; Li L
    Neurobiol Aging; 2006 Nov; 27(11):1632-43. PubMed ID: 16236385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
    Heikkinen T; Kalesnykas G; Rissanen A; Tapiola T; Iivonen S; Wang J; Chaudhuri J; Tanila H; Miettinen R; Puoliväli J
    Exp Neurol; 2004 May; 187(1):105-17. PubMed ID: 15081593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
    Morgan D; Diamond DM; Gottschall PE; Ugen KE; Dickey C; Hardy J; Duff K; Jantzen P; DiCarlo G; Wilcock D; Connor K; Hatcher J; Hope C; Gordon M; Arendash GW
    Nature; 2000 Dec 21-28; 408(6815):982-5. PubMed ID: 11140686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
    Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC
    J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
    Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.